Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant based » significant barrier (Expand Search), significant burden (Expand Search), significant causal (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
Showing 1,081 - 1,100 results of 21,342 for search '(( ((significant based) OR (significant cause)) decrease ) OR ( significant decrease decrease ))', query time: 0.62s Refine Results
  1. 1081
    Referral rate and rates of different refractive errors according to the different referral criteria.

    Referral rate and rates of different refractive errors according to the different referral criteria. by Zahi Wehbi (14863016)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1082
    Demographics of all study participants (n = 308 students; 616 eyes).

    Demographics of all study participants (n = 308 students; 616 eyes). by Zahi Wehbi (14863016)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1083
    The sets of referral criteria applied in the study.

    The sets of referral criteria applied in the study. by Zahi Wehbi (14863016)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1084
    Phosphatidylcholine (PC) decreases the nuclear c-Fos and c-Jun protein levels under lipopolysaccharide (LPS) stimulation in MG6 cells.

    Phosphatidylcholine (PC) decreases the nuclear c-Fos and c-Jun protein levels under lipopolysaccharide (LPS) stimulation in MG6 cells. by Sachiko Mizuno (21799645)

    Published 2025
    Save to List
    Saved in:
  5. 1085
    Structure-based alignment and homology modelling of MeTIR domains.

    Structure-based alignment and homology modelling of MeTIR domains. by Bulelani L. Sizani (21485746)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1086
    (A) Hierarchical clustering results of differential proteins in the Model.vs.WKY; (B) Differential protein enrichment bar chart in the Model.vs.WKY; (C) Significantly enriched pathways and those in the pathway Protein/protein coding genes and protein interaction network.

    (A) Hierarchical clustering results of differential proteins in the Model.vs.WKY; (B) Differential protein enrichment bar chart in the Model.vs.WKY; (C) Significantly enriched path... by Xiao Zhang (152326)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1087
    PRV UL4 augments ASC oligomerization and speck formation.

    PRV UL4 augments ASC oligomerization and speck formation. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 1088
    Standardized estimation of centrality index.

    Standardized estimation of centrality index. by Song Chen (69646)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1089
    Baseline and post-treatment results of categorical electrocardiographic variables in each study group.

    Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1090
    Line graph showing the values of inflammatory cytokines at baseline and after treatment.

    Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1091
    Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group.

    Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1092
    Baseline and post-treatment results of quantitative electrocardiographic variables in each study group.

    Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1093
    CONSORT diagram illustrating patient flow during the study.

    CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1094
    Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.

    Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1095
    Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease.

    Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1096
    Clinical and Demographic Characteristics of the Study Population.

    Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1097
    Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients.

    Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1098
    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.

    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1099
    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1100
    Variables obtained from the SF-36 quality of life questionnaire in each experimental group.

    Variables obtained from the SF-36 quality of life questionnaire in each experimental group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: